Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Warning Ignored on Steroid Shots Tied to Deaths
Bloomberg
Wednesday, January 25, 2012 - 9:30am
tags:
Bristol-Myers Squibb, FDA, Kenalog
Takeda’s Daxas Fails to Win U.K. Cost Agency’s Backing
Bloomberg
Wednesday, January 25, 2012 - 9:29am
tags:
Daxas, Takeda, UK, COPD
Did Stiefel undervalue employee shares before GSK buyout?
Fierce Pharma
Tuesday, January 24, 2012 - 5:34pm
tags:
Stiefel Labs, GSK
Watson Buys Ascent Pharmahealth
Yahoo/Zacks
Tuesday, January 24, 2012 - 5:14pm
tags:
Ascent Pharmahealth, Watson Pharmaceuticals, M&A
Big Pharma’s New Drugs Counteract Patent Cliff: Moody’s
Barron's
Tuesday, January 24, 2012 - 5:12pm
tags:
patents, patent cliff, JNJ, Novartis
The Good and Bad of Johnson & Johnson
Motley Fool
Tuesday, January 24, 2012 - 5:11pm
tags:
JNJ
Gilead not immune to concern over Truvada’s wider HIV use
FT.com
Tuesday, January 24, 2012 - 11:22am
tags:
HIV, Truvada, Gilead
Insmed shares spike after FDA lifts hold
Fierce Biotech
Tuesday, January 24, 2012 - 11:19am
tags:
Insmed, FDA, Arikace, antibiotics
Novo crafts fast-track R&D model for new diabetes drug unit
Fierce Biotech
Tuesday, January 24, 2012 - 11:18am
tags:
Novo Nordisk, R&D, diabetes
Pfizer Dividend Capture With A Call Option Hedge
Seeking Alpha
Tuesday, January 24, 2012 - 11:17am
tags:
Pfizer, dividends, call options
Watson 2011 earnings jump on generic drug launches
Yahoo/AP
Tuesday, January 24, 2012 - 11:16am
tags:
Watson, earnings
J&J earnings hit by litigation and recalls
FT.com
Tuesday, January 24, 2012 - 10:58am
tags:
earnings, JNJ, recalls
Roche Settles Claims Over Genentech’s Raptiva Psoriasis Drug, Lawyer Says
Bloomberg
Tuesday, January 24, 2012 - 10:57am
tags:
Raptiva, settlements, Roche, Genentech, psoriasis
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race
Xconomy
Tuesday, January 24, 2012 - 10:56am
tags:
Allos, Vertex, hepatitis C, Telaprevir, Incivek
Stem Cell Treatment for Eye Diseases Shows Promise
NY Times, NY
Tuesday, January 24, 2012 - 10:49am
tags:
stem cells, blindness, Geron, Advanced Cell Technologies, macular degeneration
Sanofi's Genzyme announces FDA approval of Framingham manufacturing plant
Yahoo/Fly on the Wall
Tuesday, January 24, 2012 - 10:47am
tags:
Sanofi, Genzyme, FDA, Fabry's disease, Fabrazyme
India's Lupin upbeat on sales outlook, shares rise
Reuters
Tuesday, January 24, 2012 - 10:46am
tags:
India, Lupin, earnings
7 High Dividend Healthcare Stocks
Seeking Alpha
Tuesday, January 24, 2012 - 10:45am
tags:
Abbott Laboratories, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, Pfizer, Lincare
Biotech Buyout Portfolio - Seattle Genetics
Seeking Alpha
Tuesday, January 24, 2012 - 10:44am
tags:
Seattle Genetics, Abbott Laboratories, Bristol-Myers Squibb, Pfizer
FDA OKs subcutaneous use of Takeda cancer drug
Reuters
Tuesday, January 24, 2012 - 10:44am
tags:
FDA, Takeda, cancer, Velcade

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.